It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.
Matthew provides mergers and acquisitions (M&A) advisory services and leads Lincoln’s U.K. strategic efforts within the healthcare sector. Matthew has nearly 20 years of M&A advisory experience, executing both sell-side and buy-side transactions for private equity clients, publicly traded companies and privately held and family-owned businesses. His experience spans both U.K. and international markets.
Matthew specializes in advising healthcare services and medical device companies and has a comprehensive understanding of these diverse markets. Matthew delivers on clients’ ambitions by providing hands-on, independent advice and leveraging the global Lincoln healthcare network.
Prior to joining Lincoln, Matthew worked at one of the “Big 4” accountancy firms as a senior member of its healthcare M&A team. Beforehand, Matthew was a private equity investor at Lloyds Development Capital and practiced healthcare M&A at Rothschild & Co in London.
Matthew earned a Bachelor of Science from the University of Bath and holds a Securities Institute Diploma.
Lincoln International represents Sovereign Capital Partners in its sale of Linnaeus Group to Mars Inc.
Lincoln International represents RIG Healthcare in its sale to Cpl Resources plc
Lincoln International advises the private equity investors Granville and Baird Capital in the sale of Amoena Group to Halder
Lincoln International represents Altaris Capital Partners in the sale of Penlon Ltd. to Goldman Sachs backed BPL Medical Technologies Private Ltd.
Perspectives featuring Matthew Lee
Webinar: Investing in Europe – Q&A on Executing and Financing Deals Post-COVID-19
Lincoln International hosted a virtual panel on January 28, 2021 featuring the firm’s experts from across Europe for a Q&A on some of the key considerations and opportunities for investors… Read More
UK Nursery Sector: Navigating the Financing Market in the COVID-19 Environment
A panel of Lincoln International’s European capital advisory and healthcare experts discuss the impact of COVID-19 on financing markets in the nursery sector. Topics covered include: Current financing market conditions… Read More
Pharmacies: The Right Prescription for Investors
Prior to the effects of COVID-19, UK community pharmacies were already undergoing significant change as a range of factors converge to transform the role of pharmacists within the primary care… Read More
Investors Take a Bite into the UK and European Dentistry Markets
Memories of nightmarish childhood trips to the dentist appear to be a thing of the past for investors as they rush to capitalise on the dentistry market in record numbers.… Read More